News
06-01-2015, 03:15 AM
Promising clinical trial results presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 show activity of the investigational anti-cancer agent ONT-380 against HER2+ breast...
More... (http://www.medicalnewstoday.com/releases/294639.php)
More... (http://www.medicalnewstoday.com/releases/294639.php)